Description
CuriRx is a certified minority woman owned company with 13,000 sqft, well equipped facility, established in 2012 and located in the Wilmington, MA. With a combined experience of over 150 years, we offer high quality development services in complex formulation, analytical method development and testing, as well an end-to-end bioprocessing solution.
Type of Drugs Manufactured:
Small Molecule;Biologics;Cell & Gene Therapy
CDMO Services:
Drug Product Formulation (FDF);Research & Development;Analytical Development
Facilities Locations:
North America
Regulatory Approvals for facilities:
ISO
Manufacturing Technologies:
Cartridges;Inhalers;Liquids;Lyophilized amps/vials;Pre-Filled Syringes (PFS)
Capabilities
- Accelerated Stability Studies
- Analytical Services
- Bioprocessing
- Cell and Gene Therapy
- Cell Culture Media Development
- Chemistry (CMC)
- Clinical Dose
- Contract Development and Manufacturing (CDMO)
- Dosage Form Development
- Downstream Processing
- Drug Development
- Feasibility Studies
- Lyophilization
- Mammalian Cell Culture
- Mass Spectrometry
- Microbial Fermentation
- Photostability
- Preformulation
- Process Characterization
- Process Development
- Process Validation Studies
- Protein and Peptide
- Research & Development
Contact Information
Related Listings

External Manufacturing Leaders Basel 2026
Exclusive event for senior external manufacturing leaders. Basel

External Manufacturing Leaders Dublin 2026
Exclusive event for senior external manufacturing leaders in Dublin, Wed 2nd December 2026











